Versartis Inc (VSAR.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|49||2015||Independent Chairman of the Board|
|59||2017||President, Chief Executive Officer, Principal Financial Officer, Director|
|42||2017||Senior Vice President, General Counsel|
|55||2017||Senior Vice President, Technical Operations|
|52||2017||Principal Accounting Officer, Vice President - Finance|
- BRIEF-Advent Life Sciences Reports 4.5 Pct Passive Stake In Versartis Inc
- BRIEF-Versartis Inc Says Board Appointed Jay Shepard, CEO, To Position Of Principal Financial Officer
- BRIEF-Versartis hires Cowen to assist in evaluating potential strategic transactions
- BRIEF-Versartis reports Q3 loss $1.40/shr
- Versartis growth hormone drug fails key study, shares sink